WeVote
Log In

Bill

Bill

A 6509

Relates to ovarian cancer research

2025 Regular Session Introduced by Amanda Septimo

A6509 funds a state ovarian cancer research program with budget oversight, affecting health agencies, researchers, hospitals, and patients.

REPORTED REFERRED TO WAYS AND MEANS
0
WeVote Research Nonpartisan
Bill Summary · A 6509

Summary: Assembly Bill A6509 (Relates to ovarian cancer research)

Overview

  • Bill number: A6509
  • Title: Relates to ovarian cancer research
  • Sponsor: Amanda Septimo (primary)
  • Introduced: March 5, 2025
  • Current status: REPORTED REFERRED TO WAYS AND MEANS
  • Version: A6509A (amendment/version associated with the bill)

Purpose and intent

  • The bill is crafted to address ovarian cancer research. While the specific text of the provisions is not included in the materials provided, the title indicates the bill’s primary focus is to advance or modify state-related activities, funding, or oversight connected to ovarian cancer research.

Key provisions (available information)

  • The exact statutory changes are not listed in the provided materials. The presence of a “Related to ovarian cancer research” label suggests potential elements such as:
    • Establishment or support of a state program or initiative focused on ovarian cancer research
    • Funding mechanisms or allocations to support research efforts
    • Reporting or oversight requirements related to ovarian cancer research activities
    • Collaboration with research institutions, hospitals, or public health entities
  • A6509A is the amendment/version associated with the bill, indicating that amendments were proposed and printed as 6509A, with actions recorded in late April 2025.

Note: Specific dollar amounts, program details, eligibility criteria, milestones, or sunset provisions are not provided in the excerpt.

Who/what would be affected

  • Likely affected entities include:
    • State government agencies (e.g., health department or related oversight bodies) if new programs or funding streams are created
    • Research institutions, universities, and hospitals engaged in ovarian cancer research
    • Patients and patient advocacy groups benefiting from enhanced research funding or initiatives
  • The bill’s movement to Ways and Means suggests fiscal implications, potentially affecting the state budget and funding allocations for research.

Procedural and timeline aspects

  • Introduced: March 5, 2025
  • Committee activity:
    • March 5, 2025: Referred to Health
    • April 25, 2025: Amendments (T) and recomitted to Health
  • Legislative actions:
    • April 25, 2025: Print number 6509A (amended version)
    • April 28, 2025: Reported and referred to Ways and Means
  • The bill has progressed from Health to the Ways and Means committee for fiscal review, a typical step for bills with budget or funding considerations.

Related legislation

  • Prior-session bills: A325, A8467, A2388, A5649, A426, A9074, A644

Practical takeaways

  • A6509 seeks to advance ovarian cancer research, with fiscal considerations likely central given its referral to Ways and Means.
  • The exact mechanisms (funding, programs, reporting) will be clarified in the text of the amended bill (A6509A) and subsequent floor action. Readers should track the bill’s progression for final provisions, budget impact, and implementation timelines.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.